Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 2
1947 2
1948 5
1949 1
1951 3
1952 7
1953 5
1955 3
1962 1
1965 1
1966 1
1968 2
1969 1
1971 2
1972 2
1973 7
1974 3
1975 9
1976 11
1977 16
1978 18
1979 16
1980 10
1981 19
1982 13
1983 24
1984 13
1985 13
1986 8
1987 23
1988 19
1989 18
1990 17
1991 18
1992 20
1993 18
1994 25
1995 19
1996 37
1997 35
1998 34
1999 32
2000 34
2001 39
2002 32
2003 47
2004 44
2005 35
2006 48
2007 61
2008 57
2009 72
2010 63
2011 73
2012 65
2013 92
2014 86
2015 103
2016 100
2017 100
2018 90
2019 103
2020 114
2021 71
Text availability
Article attribute
Article type
Publication date

Search Results

1,873 results
Results by year
Filters applied: . Clear all
Page 1
Glucagon-like peptide 1 (GLP-1).
MĆ¼ller TD, Finan B, Bloom SR, D'Alessio D, Drucker DJ, Flatt PR, Fritsche A, Gribble F, Grill HJ, Habener JF, Holst JJ, Langhans W, Meier JJ, Nauck MA, Perez-Tilve D, Pocai A, Reimann F, Sandoval DA, Schwartz TW, Seeley RJ, Stemmer K, Tang-Christensen M, Woods SC, DiMarchi RD, Tschƶp MH. MĆ¼ller TD, et al. Among authors: holst jj. Mol Metab. 2019 Dec;30:72-130. doi: 10.1016/j.molmet.2019.09.010. Epub 2019 Sep 30. Mol Metab. 2019. PMID: 31767182 Free PMC article. Review.
Glucagon Receptor Signaling and Glucagon Resistance.
Janah L, Kjeldsen S, Galsgaard KD, Winther-SĆørensen M, Stojanovska E, Pedersen J, Knop FK, Holst JJ, Wewer Albrechtsen NJ. Janah L, et al. Among authors: holst jj. Int J Mol Sci. 2019 Jul 5;20(13):3314. doi: 10.3390/ijms20133314. Int J Mol Sci. 2019. PMID: 31284506 Free PMC article. Review.
Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy.
Gide TN, Quek C, Menzies AM, Tasker AT, Shang P, Holst J, Madore J, Lim SY, Velickovic R, Wongchenko M, Yan Y, Lo S, Carlino MS, Guminski A, Saw RPM, Pang A, McGuire HM, Palendira U, Thompson JF, Rizos H, Silva IPD, Batten M, Scolyer RA, Long GV, Wilmott JS. Gide TN, et al. Among authors: holst j. Cancer Cell. 2019 Feb 11;35(2):238-255.e6. doi: 10.1016/j.ccell.2019.01.003. Cancer Cell. 2019. PMID: 30753825 Free article.
Insulin and Glucagon: Partners for Life.
Holst JJ, Holland W, Gromada J, Lee Y, Unger RH, Yan H, Sloop KW, Kieffer TJ, Damond N, Herrera PL. Holst JJ, et al. Endocrinology. 2017 Apr 1;158(4):696-701. doi: 10.1210/en.2016-1748. Endocrinology. 2017. PMID: 28323959 Free PMC article. Review.
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist.
Willard FS, Douros JD, Gabe MB, Showalter AD, Wainscott DB, Suter TM, Capozzi ME, van der Velden WJ, Stutsman C, Cardona GR, Urva S, Emmerson PJ, Holst JJ, D'Alessio DA, Coghlan MP, Rosenkilde MM, Campbell JE, Sloop KW. Willard FS, et al. Among authors: holst jj. JCI Insight. 2020 Sep 3;5(17):e140532. doi: 10.1172/jci.insight.140532. JCI Insight. 2020. PMID: 32730231 Free PMC article.
Whole grain-rich diet reduces body weight and systemic low-grade inflammation without inducing major changes of the gut microbiome: a randomised cross-over trial.
Roager HM, Vogt JK, Kristensen M, Hansen LBS, IbrĆ¼gger S, MƦrkedahl RB, Bahl MI, Lind MV, Nielsen RL, FrĆøkiƦr H, GĆøbel RJ, Landberg R, Ross AB, Brix S, Holck J, Meyer AS, Sparholt MH, Christensen AF, Carvalho V, Hartmann B, Holst JJ, Rumessen JJ, Linneberg A, Sicheritz-PontĆ©n T, Dalgaard MD, Blennow A, Frandsen HL, Villas-BĆ“as S, Kristiansen K, Vestergaard H, Hansen T, EkstrĆøm CT, Ritz C, Nielsen HB, Pedersen OB, Gupta R, Lauritzen L, Licht TR. Roager HM, et al. Among authors: holst jj. Gut. 2019 Jan;68(1):83-93. doi: 10.1136/gutjnl-2017-314786. Epub 2017 Nov 1. Gut. 2019. PMID: 29097438 Free PMC article. Clinical Trial.
The Liver-Ī±-Cell Axis and Type 2 Diabetes.
Wewer Albrechtsen NJ, Pedersen J, Galsgaard KD, Winther-SĆørensen M, Suppli MP, Janah L, Gromada J, Vilstrup H, Knop FK, Holst JJ. Wewer Albrechtsen NJ, et al. Among authors: holst jj. Endocr Rev. 2019 Oct 1;40(5):1353-1366. doi: 10.1210/er.2018-00251. Endocr Rev. 2019. PMID: 30920583 Review.
1,873 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page